| E-Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Obesity > Burden of Obesity |
|
E-Articles - Burden of Obesity
The burden of obesity has reached epidemic proportions. There are more than a billion overweight people in the world .The economic boom has led to the obesity boom. A typical example is China. Wit According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product h the decline in physical –work, more motorized transport and more television viewing, there has been a major shift in diet from cereals to animal products. And add to all this the unprecedented ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in growth in the consumption of soft –drinks and you will very soon hear of China doing a global trade in Sumo –wrestlers. Like all Chinese products, Sumos would be imported by the Japanese at half t lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. he cost of their own wrestlers or better still they might set up a manufacturing base in Beijing. The scenario is no exception to China. Obesity is a worldwide phenomenon. In the United States, 5 here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe 8 million adults are overweight. 40 million are obese and 3 million suffer from life-threatening obesity (morbid obesity). The obesity boom is a boon to the profits of the pharmaceutical companie d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro s. Most diet drugs companies are trying to invent genuine solutions to the problems of overweight and obesity. They have tried amphetamine-type diet pills, now they are producing diet pills that ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc work on the brain to suppress appetite, or in the gut to inhibit the amount of fat (and calories) digested. And even though prescription-only diet pills are regulated. In short, like all drugs, di easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi et pills carry health risks. In addition, as stated above, OTC diet and weight loss pills are becoming more powerful yet remain unregulated. Without doubt, this has allowed certain pill-manufactu nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically rers to promote useless, even dangerous diet pills as the solution to weight loss without any evidence to support such weight-loss claims. Examples of prescription diet pills include brands like: and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ Meridia (Sibutramine), Xenical (Orlistat), Adipex, Bontril, Didrex, Phentermine and Tenuate. Phentermine is an appetite suppressant, helping users curtail overeating. They are currently sold as ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi Ionamin and Adipex Adipex is the best selling brand name of Phentermine, (FEN-ter-meen). Adipex is the most effective weight loss drug on the market. It's an appetite suppressant used along with ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a diet, exercise, and behavior therapy for the short-term management of obesity. This medicine works by stimulating your hypothalamus gland, and affects certain neurotransmitters to decrease your a dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ppetite. It's used with an overall plan to reduce your weight. Adipex hydrochloride is similar chemically to amphetamines. It has the potential for psychological dependency so you should use with cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin caution. Didrex is a prescription medication designed to help users lose weight by functioning as appetite suppressant. In this sense, it is intended to prevent weight gain rather than cure the e tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen xcess fat after its absorption in the body. Like many weight loss medications, it is typically prescribed only to the very obese who are at risk for serious health risks as a result. Because of ce t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel rtain side effects it is only suitable for short term use. Xenical is a weight loss medication based on Orlistat, which acts as a lipase inhibitor by letting part of the fat consumed pass through ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust the intestine without being absorbed. Xenical has proven to be effective and especially suitable for patients suffering from diabetes, high blood pressure or heart disease, as it is not affecting y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products the patient’s metabolic rate. Meridia is an appetite suppressant used along with diet, exercise, and behavior therapy for the short-term management of obesity. It's important to balance the hea . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de lth and side effects of weight loss pills with the risks of obesity. Remember, prescription diet pills are designed for patients who already have significant health risks. Side effects of prescrip elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip tion pills that decrease appetite include things like: restlessness or tremor, nervousness or anxiety, headache or dizziness, insomnia, dry mouth, diarrhea, constipation, or worse still impotence. tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Statutes of Limitiation: Child Abuse Using Application Processor Prototyping to Create Specific Prototypes Civil War - The Curtain Drawn Aside
|